Trial results prompt scientists to call for greater use of stenting in left main artery
This article was originally published in Clinica
Executive Summary
Using stents to treat patients with left main coronary artery disease is safe and effective in the long term, a study has found. The SYNTAX-LE MANS substudy also concluded that drug-eluting stents (DESs) were a better choice than bare-metal stents (BMSs). The LE MANS registry enrolled 252 patients with unprotected left main coronary artery disease (ULMCA). In total, BMSs were used in 158 patients and DESs in 94 (37.3%). Within the DES group, paclitaxel-eluting stents were used in 60 (63.8%) patients, whereas limus analogue-eluting stents were used in 34 (36.2%) patients.
You may also be interested in...
ITF Has A Fight On Its Hands In Duchenne
The group’s new muscular dystrophy pill seems unlikely to cut into Sarepta’s sales.
AbbVie Needs To Freshen Up
With half of its 2023 sales coming from aging blockbusters like Humira and Botox, AbbVie needs new blood.
AstraZeneca Pays $2bn To Keep Up With The Joneses
Bristol Myers Squibb and Lilly have recently done billion-dollar radiopharmaceuticals deals, and now the UK group wants a piece of the market. But can it make its Fusion fusion work?